Selected article for: "alpha beta gamma and beta gamma"
Author: Moreira-Soto, Andres; Arguedas, Mauricio; Brenes, Hebleen; Buján, Willem; Corrales-Aguilar, Eugenia; Díaz, Cecilia; Echeverri, Ann; Flores-Díaz, Marietta; Gómez, Aarón; Hernández, Andrés; Herrera, María; León, Guillermo; Macaya, Román; Kühne, Arne; Molina-Mora, José Arturo; Mora, Javier; Sanabria, Alfredo; Sánchez, Andrés; Sánchez, Laura; Segura, Álvaro; Segura, Eduardo; Solano, Daniela; Soto, Claudio; Stynoski, Jennifer L.; Vargas, Mariángela; Villalta, Mauren; Reusken, Chantal B E M; Drosten, Christian; Gutiérrez, José María; Alape-Girón, Alberto; Drexler, Jan Felix
Title: High efficacy of therapeutic equine hyperimmune antibodies against SARS-CoV-2 variants of concern
  • Cord-id: bf6vjbu0
  • Document date: 2021_6_14
    • ID: bf6vjbu0
    Snippet: SARS-CoV-2 variants of concern (VoC) show reduced neutralization by vaccine-induced and therapeutic monoclonal antibodies. We tested therapeutic equine polyclonal antibodies (pAbs) against four VoC (alpha, beta, epsilon and gamma). We show that equine pAbs efficiently neutralize VoC, suggesting they are an effective, broad coverage, low-cost and a scalable COVID-19 treatment.
    Document: SARS-CoV-2 variants of concern (VoC) show reduced neutralization by vaccine-induced and therapeutic monoclonal antibodies. We tested therapeutic equine polyclonal antibodies (pAbs) against four VoC (alpha, beta, epsilon and gamma). We show that equine pAbs efficiently neutralize VoC, suggesting they are an effective, broad coverage, low-cost and a scalable COVID-19 treatment.

    Search related documents:
    Co phrase search for related documents
    • Try single phrases listed below for: 1